Sailong Pharmaceutical Group Co.,Ltd. (SHE:002898)

SHE:002898 Revenue

Sailong Pharmaceutical Group had revenue of 153.50M CNY in the quarter ending March 31, 2026, with 183.79% growth. This brings the company's revenue in the last twelve months to 618.17M, up 149.09% year-over-year. In the year 2025, Sailong Pharmaceutical Group had annual revenue of 518.76M with 96.82% growth.

• Revenue (ttm): 618.17M
• Revenue Growth: +149.09%
• P/S Ratio: 2.36
• Revenue / Employee: 1.48M
• Employees: 418
• Market Cap: 1.46B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	518.76M	255.20M	96.82%
Dec 31, 2024	263.57M	-47.06M	-15.15%
Dec 31, 2023	310.63M	46.43M	17.58%
Jan 1, 2023	264.19M	17.11M	6.93%
Jan 1, 2022	247.08M	126.39M	104.73%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 1, 2026

Data Sources Report a data error